drugset / Trial / NCT04938011

A Randomized Controlled Study of Prolonging the Time of Progesterone Supplementation to Improve the Pregnancy Outcome of Single Day 6 Blastocyst Transfer of Freeze-thaw Cycle

NCT04938011

Phase 2 Unknown 900 enrolled Nanjing University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a single-center, prospective, randomized controlled study. Patients with single blastocyst transfer in the freeze-thaw cycle, aged from 20 to 38 years, with less than three transfers, and with HRT-cycle single D6 blastocyst transfer in the current cycle were enrolled as the study participants. They were randomized into two groups using an Excel table, and the efficacy was evaluated in a blinded manner by a third party who was unaware of the grouping; the data summary phase was performed by blinded statistical analysis with triple separation of the investigator, operator, and statistician.

Timeline

Start
2021-07
Primary completion
2023-06
Completion
2024-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified

Indications